Biocon Biologics enhances its cancer treatment offerings with the introduction of three key biosimilar products.
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Limited, has announced plans to expand its oncology portfolio with the introduction of three new biosimilar candidates. The new additions include biosimilar versions of Trastuzumab/Hyaluronidase, Nivolumab, and...
The High Court has asked Novo Nordisk to respond to Natco’s request to cancel its patent.
The Delhi High Court has ordered Novo Nordisk, a Danish pharmaceutical company, to respond to a petition filed by Natco Pharma, a Hyderabad-based company, seeking to revoke the patent on the diabetes and anti-obesity drug semaglutide. The patent, which is set to...
Sun Pharmaceutical Industries suffers loss in trademark dispute as Bombay High Court rules EsiRaft and Raciraft do not bear deceptive similarities.
The Bombay High Court has ruled in favor of Eris Lifesciences, dismissing Sun Pharmaceutical's claim that Eris's medication "EsiRaft" infringed on Sun Pharma's trademark for their medication "Raciraft". The court found that the names "EsiRaft" and "Raciraft" are not...
PolyPeptide forms partnership with Lupin | Speciality Chemicals Magazine
PolyPeptide, a leading manufacturer of peptides, has formed a strategic alliance with Lupin Manufacturing Solutions. The partnership aims to establish a framework for long-term cooperation, focusing on integrated procurement and supply planning for select raw...
National Pharmaceutical Pricing Authority Caps Retail Price of Sun Pharma’s Gemcitabine Injections
The National Pharmaceutical Pricing Authority (NPPA) has set the retail price for Sun Pharma's Gemcitabine injections. Gemcitabine is a chemotherapy medication used to treat various types of cancer, including pancreatic, breast, ovarian, and non-small cell lung...
GCC will operate dialysis centers in Kolathur and Kondithope.
The Greater Chennai Corporation (GCC) will oversee and maintain two dialysis centers being constructed by the Chennai Metropolitan Development Authority (CMDA) in Kolathur and Kondithope. The centers will provide blood purification services, and the GCC has proposed...
Aurobindo Pharma Pushes Back Deadline to Purchase 26% Stake in Swarnaakshu Solar
Aurobindo Pharma has extended the timeline to acquire a 26% stake in Swarnaakshu Solar, a solar power company. The acquisition is part of Aurobindo Pharma's strategy to diversify its business and invest in renewable energy. The company had initially planned to...
Delhi High Court bars Dr Reddy’s from producing VENUSIA sunscreens bearing the SUN logo.
The Delhi High Court has issued an interim order restraining Dr. Reddy's Laboratories from manufacturing and selling its VENUSIA sunscreens with a label that includes the word "SUN". The court's decision comes in response to a lawsuit filed by Glenmark...
Sun Pharmaceutical Industries suffers loss in trademark dispute as Bombay High Court rules EsiRaft and Raciraft do not bear deceptive similarities.
The Bombay High Court has ruled in favor of Eris Lifesciences, dismissing Sun Pharmaceutical's claim that Eris's medication "EsiRaft" infringed on Sun Pharma's trademark for their medication "Raciraft". The court found that the names "EsiRaft" and "Raciraft" are not...
National Pharmaceutical Pricing Authority Caps Retail Price of Sun Pharma’s Gemcitabine Injections
The National Pharmaceutical Pricing Authority (NPPA) has set the retail price for Sun Pharma's Gemcitabine injections. Gemcitabine is a chemotherapy medication used to treat various types of cancer, including pancreatic, breast, ovarian, and non-small cell lung...
Bombay High Court Denies Sun Pharma’s Request for Temporary Restraining Order Against Competitor EsiRaft, Allowing it to Continue Challenging RACIRAFT
The Bombay High Court has refused to grant an interim injunction to Sun Pharmaceutical Industries Limited, allowing Meghmani Lifesciences Limited to continue using the trademark "EsiRaft" for its pharmaceutical product. The court found that the mark is not deceptively...
Sun Pharma Wins Reprieve as CESTAT Sends Back Rs. 3.90 Crore Excise Demand for Re-Assessment Over EOU DTA Sales and Deemed Exports – Juris Hour
The Customs, Excise, and Service Tax Appellate Tribunal (CESTAT) has remanded a Rs. 3.90 crore excise demand against Sun Pharmaceutical Industries Ltd. regarding sales from an Export Oriented Unit (EOU) to a Domestic Tariff Area (DTA). The tribunal has directed the...
The US FDA has issued a recall for an antifungal shampoo manufactured by Sun Pharma.
The US Food and Drug Administration (USFDA) has announced a recall of over 17,000 units of antifungal shampoo, Ciclopirox Shampoo, due to manufacturing issues. The recall was initiated by Taro Pharmaceutical Industries, the US arm of Sun Pharma, on December 9. The...
The Delhi High Court has ruled that a lawsuit filed by Sun Pharma is admissible, citing the company’s online presence as a relevant factor.
The Delhi High Court has ruled that a lawsuit filed by Sun Pharmaceutical Industries against a company selling a product called "PEPFIX-NEOVITAL" is maintainable. The court's decision was based on the fact that the defendant company has an online presence, which...
Sun Pharmaceutical Industries has secured approval from the US Food and Drug Administration for an updated label of UNLOXCYT, incorporating long-term efficacy data for Cutaneous Squamous Cell Carcinoma treatment.
Sun Pharmaceutical Industries Ltd. has received approval from the US Food and Drug Administration (USFDA) for an updated label for its medication UNLOXCYT (tretinoin), which is used to treat a rare skin condition called Cutaneous Squamous Cell Carcinoma (CSCC) in...
Sun Pharma Secures Rs 828 Crore Refund as CESTAT Declares Revenue Department’s Demand as Legally Invalid
Sun Pharmaceutical Industries, one of India's largest pharmaceutical companies, has won a significant excise refund battle. The Customs, Excise, and Service Tax Appellate Tribunal (CESTAT) ruled in favor of Sun Pharma, dismissing a revenue demand of Rs 828 crore...
The High Court has asked Novo Nordisk to respond to Natco’s request to cancel its patent.
The Delhi High Court has ordered Novo Nordisk, a Danish pharmaceutical company, to respond to a petition filed by Natco Pharma, a Hyderabad-based company, seeking to revoke the patent on the diabetes and anti-obesity drug semaglutide. The patent, which is set to...
Does Investing in NATCO Pharma (NSE:NATCOPHARM) Come with Significant Risks?
The article discusses the importance of considering debt when assessing a company's risk, as stated by Charlie Munger, a renowned investor. Li Lu, a fund manager backed by Berkshire Hathaway, emphasizes that the biggest investment risk is not price volatility, but the...
The Biosecure Act presents opportunities for growth and expansion in the Indian pharmaceutical industry.
The Biosecure Act has created new opportunities for the Indian pharmaceutical industry. The Act, which aims to regulate the use of biotechnology and ensure the safe handling of biological materials, has opened doors for Indian pharma companies to engage in the...
Natco Pharma’s credit rating has been reaffirmed with increased limits, highlighting its robust financial standing.
Natco Pharma, a prominent pharmaceutical company, has recently had its credit rating reaffirmed, accompanied by an enhancement of its credit limits. This development is a testament to the company's robust financial profile and its ability to maintain a strong fiscal...
Divi’s Laboratories Receives Clean Chit from US FDA with No Observations – scanx.trade
Divi's Laboratories, a leading pharmaceutical company, has successfully cleared a US FDA inspection with zero observations. This significant achievement demonstrates the company's commitment to quality and compliance with regulatory standards. The inspection, which...
The US Food and Drug Administration (USFDA) has conducted an inspection of Unit 1 at Divi’s Laboratories Limited.
The US Food and Drug Administration (USFDA) recently conducted an inspection of Unit 1 of Divi's Laboratories Limited, a leading pharmaceutical company based in India. The inspection was a routine evaluation of the company's compliance with current Good Manufacturing...
Natco Pharma’s Q2 net profit plunges 23.44% to Rs 517.9 crore
Natco Pharma, a leading Indian pharmaceutical company, has reported a decline in its net profit for the second quarter (Q2) of the current financial year. The company's net profit stood at Rs 517.9 crore, which represents a decline of 23.44% compared to the same...
Indian pharmaceutical companies Cipla, Natco, Hetero, and Annora have secured major contracts to supply generic drugs to the Chinese market.
Cipla, Natco, Hetero, and Annora, four prominent Indian pharmaceutical companies, have secured significant contracts to supply generic drugs to China. This development marks a major breakthrough for Indian pharmaceutical companies in the Chinese market. The contracts...
Biocon Biologics enhances its cancer treatment offerings with the introduction of three key biosimilar products.
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Limited, has announced plans to expand its oncology portfolio with the introduction of three new biosimilar candidates. The new additions include biosimilar versions of Trastuzumab/Hyaluronidase, Nivolumab, and...
The High Court has asked Novo Nordisk to respond to Natco’s request to cancel its patent.
The Delhi High Court has ordered Novo Nordisk, a Danish pharmaceutical company, to respond to a petition filed by Natco Pharma, a Hyderabad-based company, seeking to revoke the patent on the diabetes and anti-obesity drug semaglutide. The patent, which is set to...
Sun Pharmaceutical Industries suffers loss in trademark dispute as Bombay High Court rules EsiRaft and Raciraft do not bear deceptive similarities.
The Bombay High Court has ruled in favor of Eris Lifesciences, dismissing Sun Pharmaceutical's claim that Eris's medication "EsiRaft" infringed on Sun Pharma's trademark for their medication "Raciraft". The court found that the names "EsiRaft" and "Raciraft" are not...
PolyPeptide forms partnership with Lupin | Speciality Chemicals Magazine
PolyPeptide, a leading manufacturer of peptides, has formed a strategic alliance with Lupin Manufacturing Solutions. The partnership aims to establish a framework for long-term cooperation, focusing on integrated procurement and supply planning for select raw...
National Pharmaceutical Pricing Authority Caps Retail Price of Sun Pharma’s Gemcitabine Injections
The National Pharmaceutical Pricing Authority (NPPA) has set the retail price for Sun Pharma's Gemcitabine injections. Gemcitabine is a chemotherapy medication used to treat various types of cancer, including pancreatic, breast, ovarian, and non-small cell lung...
GCC will operate dialysis centers in Kolathur and Kondithope.
The Greater Chennai Corporation (GCC) will oversee and maintain two dialysis centers being constructed by the Chennai Metropolitan Development Authority (CMDA) in Kolathur and Kondithope. The centers will provide blood purification services, and the GCC has proposed...
Aurobindo Pharma Pushes Back Deadline to Purchase 26% Stake in Swarnaakshu Solar
Aurobindo Pharma has extended the timeline to acquire a 26% stake in Swarnaakshu Solar, a solar power company. The acquisition is part of Aurobindo Pharma's strategy to diversify its business and invest in renewable energy. The company had initially planned to...
Delhi High Court bars Dr Reddy’s from producing VENUSIA sunscreens bearing the SUN logo.
The Delhi High Court has issued an interim order restraining Dr. Reddy's Laboratories from manufacturing and selling its VENUSIA sunscreens with a label that includes the word "SUN". The court's decision comes in response to a lawsuit filed by Glenmark...
Cipla collaborates with Stempeutics to introduce revolutionary stem cell treatment for osteoarthritis of the knee.
Cipla, a leading pharmaceutical company, has partnered with Stempeutics, a stem cell therapy company, to launch a stem cell-based treatment for knee osteoarthritis in India. This innovative therapy aims to provide relief to patients suffering from knee osteoarthritis,...
Cipla inaugurates a specialized lung health diagnostic facility in the nation’s capital, Delhi.
Cipla, a leading pharmaceutical company, has launched a dedicated lung health diagnostics centre in Delhi, India. This initiative is part of the company's efforts to reimagine Indian healthcare and provide comprehensive care to patients with respiratory diseases. The...
Cipla Inaugurates India’s Pioneer Comprehensive Lung Wellness Facility in Delhi
Cipla, a leading pharmaceutical company, has launched India's first fully integrated Breathefree Lung Wellness Center in Delhi. The center, located in Lajpat Nagar, offers a comprehensive range of services, including over 60 diagnostic tests, pulmonary rehabilitation,...
Indian pharmaceutical companies Cipla, Natco, Hetero, and Annora have secured major contracts to supply generic drugs to the Chinese market.
Cipla, Natco, Hetero, and Annora, four prominent Indian pharmaceutical companies, have secured significant contracts to supply generic drugs to China. This development marks a major breakthrough for Indian pharmaceutical companies in the Chinese market. The contracts...
Eli Lilly’s Mounjaro achieves ₹1 billion in monthly sales in India’s pharma market through partnership with Cipla.
Eli Lilly's diabetes medication, Mounjaro, has achieved unprecedented success in India's pharmaceutical market, crossing ₹1 billion in monthly sales. This remarkable feat is a result of the company's strategic partnership with Cipla, a leading Indian pharmaceutical...
Cipla Limited Announces Acquisition of 100% Stake in Inzpera Healthsciences at ₹110.65 Crore – geneonline.com
Cipla Limited, a leading pharmaceutical company, has announced its plans to acquire a 100% stake in Inzpera Healthsciences Private Limited, a healthcare startup, for a consideration of ₹110.65 crore. This acquisition is expected to strengthen Cipla's presence in the...
Cipla appoints Achin Gupta as its new CEO, effective April 2026, in addition to his current role as Chief Operating Officer.
Indian pharmaceutical company Cipla Ltd has announced a change in its leadership, with current Chief Operating Officer (COO) Achin Gupta set to take over as the company's next Chief Executive Officer (CEO) and Managing Director. Gupta will succeed Umang Vohra, who has...
Cipla names Achin Gupta as new Managing Director and Global Chief Executive Officer, set to take office on April 1, 2026.
Cipla Limited, a leading pharmaceutical company, has announced the appointment of Achin Gupta as its new Managing Director and Global Chief Executive Officer (MD & GCEO), effective April 1, 2026. Gupta will succeed Umang Vohra, who has led the company since 2016. This...
GCC will operate dialysis centers in Kolathur and Kondithope.
The Greater Chennai Corporation (GCC) will oversee and maintain two dialysis centers being constructed by the Chennai Metropolitan Development Authority (CMDA) in Kolathur and Kondithope. The centers will provide blood purification services, and the GCC has proposed...
Experts from Apollo, Aster CMI, and Fortis warn that snoring may be a warning sign of underlying heart issues, citing five key reasons.
Persistent, loud snoring is often dismissed as a harmless nighttime habit, but it can be a warning sign of obstructive sleep apnea (OSA), a condition that puts the heart under constant stress. According to leading medical experts, OSA can lead to high blood pressure,...
According to Apollo doctors, adopting this one simple habit can significantly lower the risk of premature heart attacks and increase lifespan.
Dr. Sudhir Kumar, a neurologist from Apollo Hospitals in Hyderabad, recently shared his personal experience of completing a half marathon after a 14-hour fasting window. Despite the distance, he maintained a comfortable pace and low heart rate, demonstrating the deep...
Renowned physician, Dr. Apollo, discloses the ideal cooking oil for individuals struggling with excess weight and elevated cholesterol levels.
The quality of cooking oil used in daily meals plays a significant role in maintaining overall health, particularly heart wellness and cholesterol balance. Dr. Sudhir Kumar, a senior doctor at Apollo Hospitals, Hyderabad, recently shared insights on the benefits of...
Apollo Hospital cardiac surgeon sets the record straight on palm oil, saying ‘it’s healthy in moderation, despite common misconceptions’.
Palm oil has been a topic of debate when it comes to health, with several misconceptions surrounding its use. To dispel these myths, Dr. Varun Bansal, a senior consultant cardiac surgeon at Indraprastha Apollo Hospitals, shared his insights on the common...
Hypertension Alert: Beyond Genetics and Sodium Intake, Expert from Apollo Uncovers Common Daily Habits Linked to Increased Blood Pressure Risk
A senior neurologist from Apollo Hospitals, Dr. Sudhir Kumar, has highlighted the importance of everyday habits in contributing to high blood pressure. While high-sodium diets and family history are well-known risk factors, Dr. Kumar emphasizes that routine behaviors,...
Indraprastha Apollo: Ambitious Expansion Plans Unveiled, Significant Growth on the Horizon?
Indraprastha Medical, also known as Indraprastha Apollo, is a multi-specialty hospital that has experienced stagnant growth in recent years. Unlike Healthcare Global Enterprises (HCG), which focuses on chronic specialty care, Indraprastha Apollo has a broader range of...
Apollo doctor sounds alarm on India’s unseen health crisis
The Alarming Rise of Childhood Obesity in India: A Growing Public Health Concern Childhood obesity has become a significant public health challenge in India, particularly in urban areas. According to Dr. Sudhir Kumar, a neurologist at Apollo Hospitals in Hyderabad,...
ABRYSVO Secures Enhanced Public Funding in Multiple Canadian Provinces for the 2025-2026 Respiratory Syncytial Virus Season
Pfizer Canada has announced that its vaccine, ABRYSVO, for the prevention of Respiratory Syncytial Virus (RSV), will be publicly funded in multiple provinces and territories across Canada for the 2025-2026 season. This decision reflects the growing recognition of the...
Pfizer’s Accord for a Healthier World initiative is redefining traditional stability study protocols.
Pfizer's Accord for a Healthier World program is a comprehensive initiative aimed at addressing healthcare disparities by providing the company's full portfolio of medicines and vaccines on a not-for-profit basis to 45 lower-income countries. However, many of these...
Experts from Apollo, Aster CMI, and Fortis warn that snoring may be a warning sign of underlying heart issues, citing five key reasons.
Persistent, loud snoring is often dismissed as a harmless nighttime habit, but it can be a warning sign of obstructive sleep apnea (OSA), a condition that puts the heart under constant stress. According to leading medical experts, OSA can lead to high blood pressure,...
The Supreme Court has issued a notice to Fortis Hospital and other parties in response to a petition seeking compensation for a brain injury.
The Supreme Court of India has issued a notice to Fortis Hospital in response to a plea filed by an 8-year-old child, Devarsh Jain, seeking compensation of Rs 1350 crore for an alleged brain injury at birth in 2017. The child, who is in a vegetative state, approached...